SERATEC

SERATEC is a French-German CDMO specializing in the development and production of active pharmaceutical ingredients (APIs) for rare and orphan diseases as well as high-value small molecules. Founded in 1970, the company provides end-to-end API solutions from molecule design through development, registration with leading regulatory agencies, and cGMP commercial production. SERATEC is FDA-registered and has been FDA-inspected for API manufacturing.